Pixyl Received the US FDA's 510(k) Approval for the Pixyl.Neuro
Shots:
- The US FDA cleared Pixyl.Neuro, AI software for brain MRI analysis that increased detection rates by 28%, accelerated MRI reading time & 83% of stable MS MRI tests to improve patient care
- Pixyl.Neuro utilizes generative AI technology to provide reliable performance in real-world applications by automatically analyzing brain MRI images to facilitate the quick detection, early diagnosis, and objective monitoring of neurological conditions
- Pixyl complied with the latest FDA AI guidelines in obtaining approval, furthermore, Pixyl.Neuro has been certified as a CE-mark class IIa under the new Medical Device Regulations in the EU
Ref: PR Newswire | Image: Pixyl
Related News:- Masimo Received the US FDA's 510(k) Approval for the Masimo W1 Medical Watch
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Kritika is a content writer at PharmaShots. She is interested in covering recent innovations from the pharma & MedTech industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
